Single chamber ventricular compared with dual chamber pacing: A review

Canadian Journal of Cardiology

Volumn 18, Issue 3, 2002, Pages 301-307

  Wong, Graham C ^a   Hadjis, Tom ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Artificial pacing; Clinical trials; Morbidity; Mortality; Quality of life

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; ELDERLY CARE; EVIDENCE BASED MEDICINE; EXERCISE TOLERANCE; FOLLOW UP; HEALTH CARE COST; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART PROTECTION; HEART VENTRICLE PACING; HEMODYNAMIC PARAMETERS; HIGH RISK PATIENT; HUMAN; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PACEMAKER FAILURE; PHYSIOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SINUS NODE DYSFUNCTION; STROKE; THROMBOEMBOLISM;

AGE FACTORS; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; EQUIPMENT DESIGN; FORECASTING; HEMODYNAMIC PROCESSES; HUMANS; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036116869     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. A brief history of cardiac pacing
2. Indications for dual-chamber pacing
3. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices
4. Recommendations for pacemaker prescription for symptomatic bradycardia
5. The 1989 world survey of cardiac pacing
6. Cardiac pacing in Canada in 1998: Working towards optimal pacing therapy
7. Who needs dual chamber pacing? The British guidelines probably exaggerate the need: Proper studies should be done
8. Influence of cardiac pacing mode on the long-term development of atrial fibrillation
9. Symptoms, cardiovascular risk profile and spontaneous ECG in paced patients: A five-year follow-up study
10. Atrial versus ventricular pacing in sinus node disease: A treatment comparison study
11. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality
12. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing
13. Long-term follow-up of patients with sick sinus syndrome: A comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups
14. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome
15. Physiologic pacing: The role of AV synchrony
16. Increase in cardiac output with rate-responsive pacemaker
17. Single-chamber cardiac pacing with activity initiated chronotropic response: Evaluation by cardiopulmonary exercise testing
18. Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers
19. Physiological versus single-rate ventricular pacing: A double-blind cross-over study
20. Quality of life during DDD and dual sensor VVIR pacing
21. Quality of life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: A long-term, double-blind, crossover study
22. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricluar rate adaptive (VVIR) pacing on neuroendocrine variables on exercise performance and symptoms in complete heart block
23. Intrapatient comparison between chronic VVIR and DDD pacing in patients affected by high degree AV block without heart failure
24. The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function
25. Comparison of atrial contribution to cardiac hemodynamics in patients with normal and severely compromised cardiac function
26. Hemodynamic effects of acute atrioventricular pacing in patients with left ventricular dysfunction
27. Doppler ultrasound measurements of cardiac output in patients with physiologic pacemakers
28. Hemodynamic benefit of atrioventricular synchrony; Prediction from baseline Doppler echocardiographic variables
29. Diastolic dysfunction in elderly patients with congestive heart failure
30. Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias
31. Rate adaptive pacing in sick sinus syndrome: Effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life
32. Predictors of thromboembolism in atrial fibrillation: II: Echocardiographic features of patients at risk
33. Left atrial size and wall motion in patients with permanent ventricular and atrial pacing
34. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing
35. Prospective randomized trial of atrial versus ventricular pacing in sick-sinus syndrome
36. Long-term follow-up of patients from randomized trial of atrial versus ventricular pacing for sick-sinus syndrome
37. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes
38. Quality of life improves after pacing in the (CTOPP), independent of pacing mode
39. Effect of pacing modality on atrial tachyarrhythmia recurrence in the tachycardiabradycardia syndrome: Preliminary results of the pacemaker atrial tachycardia trial
40. Atrial pacing periablation for prevention of atrial fibrillation
41. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation